Maintenance of Sitagliptin During Initiation and Titration of Insulin Glargine A total of 746 patients with type 2 diabetes mellitus (mean baseline HbA1C 8.8%, disease duration 10.8 years) participated in a 30-week, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of continuing sitagliptin during the initiation and uptitration of insulin glargine
The best alternative depends on your individual health goals, but FDA-approved options like Wegovy, Mounjaro, and compounded semaglutide are commonly recommended
Needle aversion is the most straightforward reason to choose the oral drops
AMPK activation and fat browning This is where the science gets genuinely exciting
This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment
Im wysza dawka i duszy czas, tym wiksza niepewno dotyczca bezpieczestwa